Advances in preclinical and clinical studies of oncolytic virus combination therapy

被引:0
|
作者
Du, Wenlong [1 ]
Na, Jintong [1 ]
Zhong, Liping [1 ,2 ]
Zhang, Pumin [1 ]
机构
[1] Guangxi Med Univ, Natl Ctr Int Res Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Diag & Ther, State Key Lab Targeting Oncol,Guangxi Key Lab Biot, Nanning, Peoples R China
[2] Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2025年 / 15卷
关键词
oncolytic virus; tumor therapy; combined treatment; clinical trials; immunity; T-CELL THERAPY; NEWCASTLE-DISEASE VIRUS; PHASE-II; IMMUNOTHERAPY; CHEMOTHERAPY; VIROTHERAPY; ADENOVIRUS; TRIAL; INJECTION; ELICITS;
D O I
10.3389/fonc.2025.1545542
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncolytic viruses represent a distinct class of viruses that selectively infect and destroy tumor cells while sparing normal cells. Despite their potential, oncolytic viruses encounter several challenges as standalone therapies. Consequently, the combination of oncolytic viruses with other therapeutic modalities has emerged as a prominent research focus. This paper summarizes the tumor-killing mechanisms of oncolytic viruses, explores their integration with radiotherapy, chemotherapy, immune checkpoint inhibitors, CAR-T, and CAR-NK therapies, and provides an overview of related clinical trials. By synthesizing these advancements, this study seeks to offer valuable insights for the clinical translation of oncolytic virus combination therapies.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
    Fergusson, Dean A.
    Wesch, Neil L.
    Leung, Garvin J.
    MacNeil, Jenna L.
    Conic, Isidora
    Presseau, Justin
    Cobey, Kelly D.
    Diallo, Jean-Simon
    Auer, Rebecca
    Kimmelman, Jonathan
    Kekre, Natasha
    El-Sayes, Nader
    Krishnan, Ramya
    Keller, Brian A.
    Ilkow, Carolina
    Lalu, Manoj M.
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 14 : 179 - 187
  • [2] Oncolytic virus preclinical toxicology studies
    Rasa, Agnija
    Alberts, Peteris
    JOURNAL OF APPLIED TOXICOLOGY, 2023, 43 (05) : 620 - 648
  • [3] Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
    Shan Jiang
    Huihui Chai
    Qisheng Tang
    Zhifeng Shi
    Liangfu Zhou
    Discover Oncology, 14
  • [4] Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
    Jiang, Shan
    Chai, Huihui
    Tang, Qisheng
    Shi, Zhifeng
    Zhou, Liangfu
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [5] Recent advances of oncolytic virus in cancer therapy
    Mondal, Moumita
    Guo, Jingao
    He, Ping
    Zhou, Dongming
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2389 - 2402
  • [6] Possibility of combination therapy using herpes oncolytic virus HF10 with Erlotinib and Gemcitabine as preclinical data for clinical trial
    Kasuya, Hideki
    Yamamura, Kazuo
    Gewen, Tan
    Sahin, Tevfik T.
    Hirooka, Yoshihiro
    Goto, Hidemi
    Kodera, Yasuhiro
    Tanaka, Maki
    HUMAN GENE THERAPY, 2014, 25 (12) : A3 - A3
  • [7] Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies
    O. V. Matveeva
    G. V. Kochneva
    S. S. Zainutdinov
    G. V. Ilyinskaya
    P. M. Chumakov
    Molecular Biology, 2018, 52 : 306 - 322
  • [8] Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies
    Matveeva, O. V.
    Kochneva, G. V.
    Zainutdinov, S. S.
    Ilyinskaya, G. V.
    Chumakov, P. M.
    MOLECULAR BIOLOGY, 2018, 52 (03) : 306 - 322
  • [9] Recent advances in oncolytic virus therapy for hepatocellular carcinoma
    Zhu, Licheng
    Lei, Yu
    Huang, Jia
    An, Yahang
    Ren, Yanqiao
    Chen, Lei
    Zhao, Huangxuan
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Advances on The Regulation of Tumor Microenvironment and Combination Therapy by Oncolytic Viruses
    Tang Lei
    Li Ping-Cui
    Li Run-Fang
    Liu Zhao-Hong
    Song Bin
    Duan Wen-Fang
    Zhang Ji-Hong
    Yang Fan
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2020, 47 (05) : 399 - 406